| Net Cash Provided by (Used in) Operating Activities |
$2,027,468,000 |
USD |
-476% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,232,876,000 |
USD |
381% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
463,690,115 |
shares |
50% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$205,408,000 |
USD |
84% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$419,328,000 |
USD |
84% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$488,953,000 |
USD |
57% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$11,625,584,000 |
USD |
51% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$293,977,000 |
USD |
199% |
Q1 2024 |
Q1 2024 |